Author:
Kunstman John W.,Nagar Anil,Gibson Joanna,Kunz Pamela L.
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Klimstra D, Klöppel G, La Rosa S, Rindi G. Classification of neuroendocrine neoplasms of the digestive system. Digestive system tumours: WHO Classification of Tumours. 5th ed. Vol. 1. IARC Press; 2019. pp. 16–9.
2. •• Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022;33(1):115–54. This manuscript describes the upcoming 2022 WHO Classification of NENS, an update to the 2019 WHO Guidelines. These are key guidelines that set the standards for pathology reporting for NENs.
3. Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117–22.
4. Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017;3(10):1335–42.
5. Mocellin S, Nitti D. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). Ann Oncol. 2013;24(12):3040–4.